160 related articles for article (PubMed ID: 3501941)
1. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Richman DD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1879-81. PubMed ID: 3501941
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
3. Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
Carter SG; Kessler JA; Rankin CD
Antimicrob Agents Chemother; 1990 Jun; 34(6):1297-300. PubMed ID: 2393292
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
5. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
Smith MS; Brian EL; Pagano JS
J Virol; 1987 Dec; 61(12):3769-73. PubMed ID: 2446006
[TBL] [Abstract][Full Text] [Related]
6. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
Baba M; Pauwels R; Herdewijn P; De Clercq E; Desmyter J; Vandeputte M
Biochem Biophys Res Commun; 1987 Jan; 142(1):128-34. PubMed ID: 3028398
[TBL] [Abstract][Full Text] [Related]
7. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
[TBL] [Abstract][Full Text] [Related]
8. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
Hammer SM; Gillis JM
Antimicrob Agents Chemother; 1987 Jul; 31(7):1046-50. PubMed ID: 2444155
[TBL] [Abstract][Full Text] [Related]
10. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA
Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293
[TBL] [Abstract][Full Text] [Related]
11. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs.
Hartmann H; Vogt MW; Durno AG; Hirsch MS; Hunsmann G; Eckstein F
AIDS Res Hum Retroviruses; 1988 Dec; 4(6):457-66. PubMed ID: 3219235
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.
Furman PA; Barry DW
Am J Med; 1988 Aug; 85(2A):176-81. PubMed ID: 3044082
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.
Hartshorn KL; Vogt MW; Chou TC; Blumberg RS; Byington R; Schooley RT; Hirsch MS
Antimicrob Agents Chemother; 1987 Feb; 31(2):168-72. PubMed ID: 3471180
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG
Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.
Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E
J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
Spector SA; Ripley D; Hsia K
Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
